1,2-dichloroethane decreases expression ISO RGD:1553872 6480464 ethylene dichloride results in decreased expression of CHRDL1 mRNA CTD PMID:28960355 17beta-estradiol decreases expression ISO RGD:1553872 6480464 Estradiol results in decreased expression of CHRDL1 mRNA CTD PMID:19484750 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1553872 6480464 Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CHRDL1 promoter] CTD PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1349204 6480464 Tetrachlorodibenzodioxin results in increased expression of CHRDL1 mRNA CTD PMID:36370075 3,7-dihydropurine-6-thione decreases expression EXP 6480464 Mercaptopurine results in decreased expression of CHRDL1 mRNA CTD PMID:23358152 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1349204 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHRDL1 mRNA more ... CTD PMID:28628672 3-Nitrobenzanthrone decreases expression ISO RGD:1349204 6480464 3-nitrobenzanthrone results in decreased expression of CHRDL1 mRNA CTD PMID:34036453 4-hydroxyphenyl retinamide decreases expression ISO RGD:1553872 6480464 Fenretinide results in decreased expression of CHRDL1 mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of CHRDL1 mRNA CTD PMID:22504374 more ... acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CHRDL1 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:1553872 6480464 Acrylamide results in decreased expression of CHRDL1 mRNA CTD PMID:29261810 aflatoxin B1 decreases methylation ISO RGD:1349204 6480464 Aflatoxin B1 results in decreased methylation of CHRDL1 gene CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CHRDL1 mRNA CTD PMID:25378103 all-trans-retinoic acid increases expression ISO RGD:1349204 6480464 Tretinoin results in increased expression of CHRDL1 mRNA CTD PMID:21934132 antirheumatic drug increases expression ISO RGD:1349204 6480464 Antirheumatic Agents results in increased expression of CHRDL1 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1349204 6480464 aristolochic acid I results in decreased expression of CHRDL1 mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1349204 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CHRDL1 mRNA] CTD PMID:32406909 arsenous acid decreases expression ISO RGD:1349204 6480464 Arsenic Trioxide results in decreased expression of CHRDL1 mRNA CTD PMID:26705709 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CHRDL1 mRNA CTD PMID:21839799 benzo[a]pyrene decreases expression ISO RGD:1349204 6480464 Benzo(a)pyrene results in decreased expression of CHRDL1 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO RGD:1349204 6480464 Benzo(a)pyrene affects the methylation of CHRDL1 5' UTR, Benzo(a)pyrene affects the methylation of CHRDL1 promoter CTD PMID:27901495 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1349204 6480464 Diethylhexyl Phthalate results in decreased expression of CHRDL1 mRNA CTD PMID:31163220 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CHRDL1 mRNA CTD PMID:25607892 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CHRDL1 mRNA CTD PMID:30816183 bisphenol A multiple interactions ISO RGD:1349204 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHRDL1 mRNA CTD PMID:28628672 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CHRDL1 mRNA CTD PMID:25181051 bisphenol F multiple interactions ISO RGD:1349204 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of CHRDL1 mRNA CTD PMID:28628672 bisphenol F affects expression ISO RGD:1553872 6480464 bisphenol F affects the expression of CHRDL1 mRNA CTD PMID:30951980 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of CHRDL1 mRNA CTD PMID:32479839 Butylparaben multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CHRDL1 mRNA CTD PMID:25607892 cadmium atom increases expression ISO RGD:1349204 6480464 Cadmium results in increased expression of CHRDL1 mRNA CTD PMID:21120746 carbamazepine affects expression ISO RGD:1349204 6480464 Carbamazepine affects the expression of CHRDL1 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1553872 6480464 Nanotubes, Carbon affects the expression of CHRDL1 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1553872 6480464 Nanotubes, Carbon analog results in decreased expression of CHRDL1 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1349204 6480464 CGP 52608 promotes the reaction [RORA protein binds to CHRDL1 gene] CTD PMID:28238834 chromium atom increases expression ISO RGD:1349204 6480464 Chromium results in increased expression of CHRDL1 mRNA CTD PMID:21437242 copper atom multiple interactions ISO RGD:1349204 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CHRDL1 mRNA CTD PMID:31162603 copper(0) multiple interactions ISO RGD:1349204 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CHRDL1 mRNA CTD PMID:31162603 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of CHRDL1 mRNA CTD PMID:27523638 dexamethasone increases expression ISO RGD:1349204 6480464 Dexamethasone results in increased expression of CHRDL1 mRNA CTD PMID:25047013 dexamethasone multiple interactions ISO RGD:1349204 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHRDL1 mRNA more ... CTD PMID:28628672 diarsenic trioxide decreases expression ISO RGD:1349204 6480464 Arsenic Trioxide results in decreased expression of CHRDL1 mRNA CTD PMID:26705709 dioxygen multiple interactions ISO RGD:1553872 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CHRDL1 mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CHRDL1 mRNA], [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of CHRDL1 mRNA CTD PMID:33729688 dorsomorphin multiple interactions ISO RGD:1349204 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1349204 6480464 entinostat results in increased expression of CHRDL1 mRNA CTD PMID:27188386 enzacamene multiple interactions EXP 6480464 [bisphenol A co-treated with enzacamene co-treated with octylmethoxycinnamate co-treated with butylparaben] affects the expression of CHRDL1 mRNA CTD PMID:25607892 ethanol multiple interactions ISO RGD:1349204 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of CHRDL1 mRNA CTD PMID:23378141 ethanol increases expression ISO RGD:1553872 6480464 Ethanol results in increased expression of CHRDL1 mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1349204 6480464 [Ethanol co-treated with Folic Acid] results in decreased expression of CHRDL1 mRNA CTD PMID:23378141 folic acid decreases expression ISO RGD:1553872 6480464 Folic Acid results in decreased expression of CHRDL1 mRNA CTD PMID:25629700 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CHRDL1 mRNA CTD PMID:33387578 indometacin multiple interactions ISO RGD:1349204 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of CHRDL1 mRNA more ... CTD PMID:28628672 lipopolysaccharide increases expression ISO RGD:1349204 6480464 Lipopolysaccharides results in increased expression of CHRDL1 mRNA CTD PMID:35811015 lipopolysaccharide multiple interactions ISO RGD:1349204 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CHRDL1 mRNA] CTD PMID:35811015 mercaptopurine decreases expression EXP 6480464 Mercaptopurine results in decreased expression of CHRDL1 mRNA CTD PMID:23358152 mercury dibromide decreases expression ISO RGD:1349204 6480464 mercuric bromide results in decreased expression of CHRDL1 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO RGD:1349204 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHRDL1 mRNA CTD PMID:27188386 methimazole increases expression EXP 6480464 Methimazole results in increased expression of CHRDL1 mRNA CTD PMID:22504374 methylmercury chloride decreases expression ISO RGD:1349204 6480464 methylmercuric chloride results in decreased expression of CHRDL1 mRNA CTD PMID:28001369 methylmercury chloride decreases expression ISO RGD:1553872 6480464 methylmercuric chloride results in decreased expression of CHRDL1 mRNA CTD PMID:29261810 mitoxantrone affects response to substance ISO RGD:1349204 6480464 CHRDL1 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1349204 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CHRDL1 mRNA CTD PMID:24810058 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CHRDL1 mRNA CTD PMID:19638242 N-Nitrosopyrrolidine decreases expression ISO RGD:1349204 6480464 N-Nitrosopyrrolidine results in decreased expression of CHRDL1 mRNA CTD PMID:32234424 nickel sulfate decreases expression ISO RGD:1349204 6480464 nickel sulfate results in decreased expression of CHRDL1 mRNA CTD PMID:22714537 ozone multiple interactions ISO RGD:1553872 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of CHRDL1 mRNA, [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of CHRDL1 mRNA CTD PMID:34911549 p-chloromercuribenzoic acid decreases expression ISO RGD:1349204 6480464 p-Chloromercuribenzoic Acid results in decreased expression of CHRDL1 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO RGD:1349204 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHRDL1 mRNA CTD PMID:27188386 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CHRDL1 mRNA CTD PMID:32479839 paracetamol increases expression ISO RGD:1349204 6480464 Acetaminophen results in increased expression of CHRDL1 mRNA CTD PMID:26690555 phenylmercury acetate decreases expression ISO RGD:1349204 6480464 Phenylmercuric Acetate results in decreased expression of CHRDL1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349204 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHRDL1 mRNA CTD PMID:27188386 potassium chromate increases expression ISO RGD:1349204 6480464 potassium chromate(VI) results in increased expression of CHRDL1 mRNA CTD PMID:22714537 potassium dichromate decreases expression ISO RGD:1553872 6480464 Potassium Dichromate results in decreased expression of CHRDL1 mRNA CTD PMID:23608068 profenofos decreases expression EXP 6480464 profenofos results in decreased expression of CHRDL1 mRNA CTD PMID:17569032 progesterone increases expression ISO RGD:1553872 6480464 Progesterone results in increased expression of CHRDL1 mRNA CTD PMID:22238285 purine-6-thiol decreases expression EXP 6480464 Mercaptopurine results in decreased expression of CHRDL1 mRNA CTD PMID:23358152 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CHRDL1 mRNA CTD PMID:28374803 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1349204 6480464 S-(1, 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of CHRDL1 mRNA] CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:1349204 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silver atom decreases expression ISO RGD:1553872 6480464 Silver results in decreased expression of CHRDL1 mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:1553872 6480464 Silver results in decreased expression of CHRDL1 mRNA CTD PMID:27131904 sodium arsenate increases expression ISO RGD:1553872 6480464 sodium arsenate results in increased expression of CHRDL1 mRNA CTD PMID:21795629 sodium arsenite affects methylation ISO RGD:1349204 6480464 sodium arsenite affects the methylation of CHRDL1 gene CTD PMID:28589171 Soman increases expression EXP 6480464 Soman results in increased expression of CHRDL1 mRNA CTD PMID:19281266 tert-butyl hydroperoxide decreases expression ISO RGD:1349204 6480464 tert-Butylhydroperoxide results in decreased expression of CHRDL1 mRNA CTD PMID:15336504 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CHRDL1 mRNA CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CHRDL1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1553872 6480464 titanium dioxide results in decreased expression of CHRDL1 mRNA CTD PMID:23557971 trichostatin A decreases expression ISO RGD:1349204 6480464 trichostatin A results in decreased expression of CHRDL1 mRNA CTD PMID:26272509 trichostatin A multiple interactions ISO RGD:1349204 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CHRDL1 mRNA CTD PMID:27188386 uranium atom increases expression ISO RGD:1349204 6480464 Uranium results in increased expression of CHRDL1 mRNA CTD PMID:15672453 valproic acid decreases methylation ISO RGD:1349204 6480464 Valproic Acid results in decreased methylation of CHRDL1 gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1349204 6480464 Valproic Acid affects the expression of CHRDL1 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1349204 6480464 Valproic Acid results in increased expression of CHRDL1 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid decreases expression ISO RGD:1553872 6480464 Valproic Acid results in decreased expression of CHRDL1 mRNA CTD PMID:29261810 XL147 multiple interactions ISO RGD:1553872 6480464 [N-nitroso-tris-chloroethylurea co-treated with XL147] results in decreased expression of CHRDL1 mRNA CTD PMID:27935865
